Salt Tablets for POTS: Recommended Regimen
For patients with POTS, you should prescribe 10 grams of sodium chloride daily, which can be administered as salt tablets, salt sticks, NaCl sachets, or high-salt foods, combined with at least 3 liters of daily fluid intake. 1
Dosing Regimen
The 2020 Canadian Cardiovascular Society guidelines provide a strong recommendation for this approach, despite low-quality evidence, because volume expansion through dietary sodium is foundational to POTS management 1. This translates to approximately:
- 10 grams (10,000 mg) of NaCl per day
- Equivalent to roughly 4,000 mg of elemental sodium daily
- Can be divided throughout the day for better tolerance
Practical Implementation
If using commercial sodium chloride oral solution (23.4% concentration), the typical dosing is 4 mL (equivalent to 936 mg NaCl) for ages 9-50 years, though total daily intake should reach the 10-gram target through multiple administrations or combination with dietary sources 2.
Supporting Evidence and Mechanism
Research demonstrates that high dietary sodium intake in POTS patients:
- Increases plasma volume significantly compared to low sodium intake 3
- Reduces standing heart rate and the magnitude of orthostatic tachycardia (Δ heart rate) 3
- Decreases standing plasma norepinephrine levels 3
- Shows most pronounced benefit in patients with baseline urinary sodium excretion <170 mmol/day 4
A 2021 randomized crossover trial comparing high sodium (300 mEq/day) versus low sodium (10 mEq/day) diets found that high sodium reduced upright heart rate and improved orthostatic tolerance, though patients remained more symptomatic than healthy controls 3.
Monitoring Requirements
Before Initiating Treatment
- Baseline blood pressure assessment - particularly supine blood pressure
- Renal function and electrolytes - ensure no contraindications
- Cardiovascular comorbidities screening - hypertension, heart failure, renal disease
During Treatment
- Monitor supine blood pressure regularly - salt supplementation should have minimal effect on supine BP in POTS patients, but this requires verification 4
- Assess symptom improvement - orthostatic tolerance, quality of life measures
- Check for adverse effects - edema, headaches, gastrointestinal symptoms
Contraindications and Cautions
Absolute contraindications:
- Uncontrolled hypertension
- Congestive heart failure
- Significant renal impairment
- Conditions requiring sodium restriction
Relative contraindications:
Important Caveats
Salt supplementation is first-line treatment but not monotherapy. The guidelines emphasize this should be combined with:
- Exercise training (semirecumbent initially) - strong recommendation with moderate-quality evidence 1
- Lower body compression garments (waist-high, 20-30 mmHg) 1
- Head-up tilt sleeping position (>10°) to promote nocturnal volume expansion 1
If patients cannot tolerate adequate oral salt intake, fludrocortisone (0.1-0.2 mg daily) may be considered as an alternative volume expansion strategy, though it requires potassium monitoring 1.
When Salt Supplementation Fails
If disabling symptoms persist despite adequate salt and fluid intake, pharmacological therapy should be added:
- Midodrine 2.5-15 mg every 4 hours (up to 3 times daily) - strong recommendation 1
- Propranolol 10-20 mg four times daily - strong recommendation 1
- Ivabradine 2.5-7.5 mg twice daily - weak recommendation 1
Acute rescue therapy with IV normal saline (1-2 L over 1-2 hours) may be considered for severe exacerbations, but chronic IV saline is not recommended due to infection and thrombosis risks 1.
Duration of Treatment
Salt supplementation should be continued long-term as tolerated, as POTS is typically a chronic condition. Short-term studies (approximately 3 months) demonstrate benefit 4, but many patients require ongoing treatment. Efficacy should be reassessed periodically, and the regimen adjusted based on symptom control and tolerance.